Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer-Reference-Cited by-同舟云学术

Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer

Published:2022-06-08 Issue:1 Volume:12 Page:584-596
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Thaiparambil Jose¹^ORCID,Dong Jianrong²³,Grimm Sandra L.²⁴⁵,Perera Dimuthu⁵,Ambati Chandra Shekar R.⁵,Putluri Vasanta⁵,Robertson Matthew J.⁴⁵,Patel Tajhal D.⁶,Mistretta Brandon⁷,Gunaratne Preethi H.³⁷,Kim Min P.¹⁸,Yustein Jason T.³⁴⁶⁹,Putluri Nagireddy³⁵^ORCID,Coarfa Cristian²³⁴⁵,El‐Zein Randa¹

Affiliation:

1. Houston Methodist Cancer Center Houston Texas USA

2. Center for Precision and Environmental Health Baylor College of Medicine Houston Texas USA

3. Molecular and Cellular Biology Department Baylor College of Medicine Houston Texas USA

4. Dan L Duncan Comprehensive Cancer Center Baylor College of Medicine Houston Texas USA

5. Advanced Technology Cores Baylor College of Medicine Houston Texas USA

6. Texas Children’s Cancer and Hematology Centers and The Faris D. Virani Ewing Sarcoma Center Baylor College of Medicine Houston Texas USA

7. Department of Biology and Biochemistry University of Houston Houston Texas USA

8. Division of Thoracic Surgery, Department of Surgery Houston Methodist Hospital Houston Texas USA

9. Integrative Molecular and Biological Sciences Program Baylor College of Medicine Houston Texas USA

Funder

National Institute of Environmental Health Sciences

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4933

Reference55 articles.

1. Targeted therapy in non-small-cell lung cancer—is it becoming a reality?

2. Multitargeted Inhibitors in Lung Cancer: New Clinical Data

3. Comparison of aspects of smoking among the four histological types of lung cancer

4. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

5. Gene Expression Profiling Reveals Reproducible Human Lung Adenocarcinoma Subtypes in Multiple Independent Patient Cohorts

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hairy-root technology: A metabolic engineering tool and specialized metabolite pathway elucidation and production of secondary metabolites. A review;Results in Engineering;2024-09

2. Metabolomic Profiling of Tumor Tissues Unveils Metabolic Shifts in Non-Small Cell Lung Cancer Patients with Concurrent Diabetes Mellitus;Journal of Proteome Research;2024-08-20

3. From Data to Diagnosis Exploring AWS Cloud Solutions in Multi-Omics Breast Cancer Biomarker Research;Computational Biology and Bioinformatics;2024-08-15

4. Bioinformatics Identification and Experimental Validation of a Prognostic Model for the Survival of Lung Squamous Cell Carcinoma Patients;Biochemical Genetics;2024-05-28

5. Integrative Omics Analysis Reveals Metabolic Features of Ground-Glass Opacity-Associated Lung Cancer;Journal of Cancer;2024